In univariate analysis, age, ECOG PS, tumor focality, administration of adjuvant chemotherapy and radiotherapy, type of surgical procedure, IDH mutation status, presence of ATRX loss, GINI, SII, SIRI, and PIV were found to be significantly associated with overall survival (p < 0.05). The gene discussed is ATRX; the disease is neoplasm.